The Pfizer is seeking applications for its Quality Improvement Grant to enhance bladder cancer care and patient experience.
Donor Name: Pfizer
State: All States
County: All Counties
Type of Grant: Grant
Deadline: 07/23/2025
Size of the Grant: $100,000 to $500,000
Grant Duration: 2 Years
Details:
There are a number of gaps that impact the experiences and outcomes of patients with bladder cancer, which may be addressed through quality improvement approaches. These include, but are not limited to:
- Addressing timely treatment initiation.
- Selecting the optimal treatment for each patient, including appropriate timing and follow up care.
- Clear communication to patients regarding treatment options and what to expect during treatment, in particular identification of adverse events.
- Shared decision making across the care team, including (but not limited to) nurses, urologists, and medical, surgical, and radiation oncologists.
- Uniform application of care guidelines across different practice settings.
- Patient access to counseling pertaining to their care to provide knowledge that empowers them to make informed decisions.
Project Types
Proposals are encouraged that address improving the patient experience and management of care throughout the bladder cancer continuum, from diagnosis to survivorship, with a specific focus on the coordination of the multi-disciplinary care of patients. This includes using established quality improvement approaches to close known gaps related to:
- Optimizing the Experience of Patients with Bladder Cancer Through Multi-Disciplinary Care
- Improved shared decision making and communication across all stakeholders along the care journey (multi-disciplinary teams, providers, and patients).
- Optimized coordination of care, including helping patients navigate their own care journey.
- Guideline(s) concordance, optimizing implementation of care and mitigating complications to improve patient outcomes.
- Providing solutions for delivering quality multi-disciplinary care for both providers and patients in diverse practice settings.
- Ensuring safe and consistent therapeutic management to optimize treatment for all patients with bladder cancer.
- Utilizing technology (data science, patient centered mobile app or AI) to improve the ease of navigating the bladder cancer treatment paradigm.
Funding Information
Individual projects requesting up to $250,000 will be considered.
Grant Period
This opportunity is intended to support quality improvement projects with an 18-24 month duration.
Target Audiences
- Target applicants include medical, surgical, and radiation oncologists, urologists, nurses, advanced practice providers and other members of the multi-disciplinary team treating patients with bladder cancer in diverse settings (including academic and community settings).
- Target population are adult patients across all stages of bladder cancer, including NMIBC, MIBC, and unresectable locally advanced or mUC. This may include patients being diagnosed with bladder cancer (e.g. those evaluated for hematuria).
Eligibility Criteria
- Community clinics treating patients with bladder cancer are highly encouraged to apply.
- The following institutions may apply: medical, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); independent practice groups; professional organizations; government agencies; and other entities with a mission related to healthcare improvement.
- Only organizations and independent practice groups are eligible to receive grants, not individual professionals or solo practices.
- The primary applicant must be US based. However, collaborative sites outside the US are permissible.
- Collaborations within institutions (e.g., between departments and/or inter-professional), as well as between different institutions / organizations / associations, are encouraged. Please note all partners must have a relevant role and the requesting organization must have a key role in the project.
- The applicant must be the Project Lead/Principal Investigator (PI) or an authorized designee of such individual (e.g., Project Lead/PI’s grant/research coordinator).
- The Project Lead/PI must be an employee or contractor of the requesting organization.
- Requesting organization must be legally able to receive award funding directly from Pfizer Inc. They strongly recommend that applicants confirm this with their organization or institution prior to submitting an application. Grants awarded to organizations that are
- subsequently found to be unable to accept funding directly from Pfizer Inc. may be subject to rescission.
- For projects offering continuing education credit, the requesting organization must be accredited.
For more information, visit Pfizer.
